WebNews
Please enter a web search for web results.
NewsWeb
'Spike proteins in tumor?': Chilling claim on 'm RNA COVID vaccines causing Cancer' at Senate hearing
7+ hour, 45+ min ago (106+ words) The Economic Times Ron Johnson, R-Wis. , held a high-stakes hearing on Capitol Hill Wednesday, focusing on COVID-19 and allegations that federal health agencies suppressed vaccine safety data and interfered with scientific studies The hearing on Wednesday, titled "Plausible Mechanisms of…...
New baldness drug boosts hair coverage by up to 86% in six months | Engineering and Technology Magazine
9+ hour, 25+ min ago (465+ words) A new oral treatment for male pattern hair loss is on the horizon following successful late-stage clinical trials. Male pattern hair loss, or androgenetic alopecia, is a very common hereditary and hormonal condition affecting men of any age. From puberty…...
Gene therapy restores hearing in deaf children
5+ hour, 32+ min ago (133+ words) Central Oregon Daily A first-of-its-kind gene therapy is helping cure a specific type of deafness. CBS's Michael George introduces us to a family whose lives are now forever changed. - Police: Bend man arrested, suspected of 'inappropriate' relationships with minor co-workers…...
Laxative Also Helps Alleviate Certain Depression Symptoms
12+ hour, 27+ min ago (435+ words) Yahoo Life UK Not only frees the gut but apparently also the soul: A medication originally used for constipation alleviates cognitive depression symptoms after just one week. These are symptoms that often persist after recovery. FITBOOK explains the background. It…...
Cutaneous Lupus Erythematosus Market Set for First Targeted Therapy in 70 Years as Approval Nears | Thelansis
8+ hour, 16+ min ago (87+ words) open PR. com Cutaneous Lupus Erythematosus Market Set for First Targeted Therapy in 70 Years as Approval Nears | Thelansis Press release from: THELANSIS KNOWLEDGE PARTNERS LLP Cutaneous Lupus Erythematosus (CLE) Market Outlook & Forecast 2026-2036 | Thelansis Permanent link to this press release: You…...
Transformational: Daraxonrasib data signal new era in pancreatic cancer
4+ hour, 7+ min ago (1348+ words) The eagerly awaited full dataset from the most pivotal pancreatic cancer study in decades didn’ t just live up to expectations. It far exceeded them....
Real-World Data Support Tocilizumab for Systemic Sclerosis
20+ hour, 4+ min ago (438+ words) EMJ This site is intended for healthcare professionals Real-World Data Support Tocilizumab for Systemic Sclerosis TOCILIZUMAB stabilises lung function and improved skin, joint, and vascular disease in people with systemic sclerosis, a 197-patient French-Italian study has found, strengthening the case…...
Congressman proposes draft legislation to accelerate US clinical trials
9+ hour, 27+ min ago (596+ words) The legislation aims to accelerate clinical trials, with a feedback date set for 30 June. A draft legislation aimed at accelerating drug discovery and clinical trials has been proposed in the US. Democratic Congressman Jake Auchincloss, the representative for Massachusetts" 4th congressional…...
Daraxonrasib Trials Redefine Pancreatic Cancer Survival Metrics
13+ hour, 42+ min ago (515+ words) streamlinefeed. co. ke...
Pancreatic cancer survival doubled: what oncologists can no longer ignore
10+ hour, 59+ min ago (670+ words) While not curing the cancer, it is a very large step forward," said Dr. Zev Wainberg of the University of California, Los Angeles, who helped lead the study. The drug, called daraxonrasib, blocks a mutated protein that fuels tumor growth…...